The efficacy of AST-120 on chronic kidney disease with stable angina: randomized controlled open-labeled trial

The efficacy of AST-120 on chronic kidney disease with stable angina: randomized controlled open-labeled trial - The efficacy of AST-120 on chronic kidney disease with stable angina

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000015419

Enrollment

Registered

2014-12-20

Start date

2015-01-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ischemic heart disease Chronic kidney disease

Interventions

AST-120 control

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: stable angina eGFR 15-45ml/min/1.732

Exclusion criteria

Exclusion criteria: patients with pregnancy

Design outcomes

Primary

Measure	Time frame
The amount of change of carotid intima-media thickness The amount of change of vascular endothelial function	—

Countries

Japan

Contacts

Public ContactSusumu Suzuki

Nagoya University Graduate School of Medicine Department of CKD Initiatives Internal Medicine

susumusuzuki@med.nagoya-u.ac.jp052-744-2202

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026